TELA Bio, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6 7
Rok finansowy 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 4 8 15 18 29 41 58 69
Przychód Δ r/r 0.0% 94.9% 86.7% 17.9% 61.8% 40.6% 41.1% 18.6%
Marża brutto 59.6% 35.6% 60.0% 61.7% 63.9% 65.3% 68.6% 67.1%
EBIT (mln) -17 -18 -19 -25 -29 -39 -44 -34
EBIT Δ r/r 0.0% 5.1% 7.8% 31.9% 16.5% 32.4% 13.0% -22.6%
EBIT (%) -398.7% -214.9% -124.1% -138.8% -100.0% -94.2% -75.4% -49.2%
Koszty finansowe (mln) 5 2 4 4 4 4 5 5
EBITDA (mln) -16 -19 -19 -25 -30 -39 -43 -32
EBITDA(%) -378.5% -225.1% -121.8% -138.5% -100.7% -94.2% -74.0% -45.7%
Podatek (mln) 5 -2 3 3 3 0 0 -0
Zysk Netto (mln) -21 -21 -26 -32 -36 -44 -47 -38
Zysk netto Δ r/r 0.0% -1.1% 22.3% 23.5% 13.3% 22.8% 5.2% -18.9%
Zysk netto (%) -502.6% -254.9% -167.1% -175.0% -122.6% -107.0% -79.8% -54.6%
EPS -3.29 -3.25 -2.26 -2.46 -2.49 -2.73 -2.04 -1.33
EPS (rozwodnione) -3.29 -3.25 -2.26 -2.46 -2.49 -2.73 -2.04 -1.33
Ilośc akcji (mln) 6 6 11 13 14 16 23 29
Ważona ilośc akcji (mln) 6 6 11 13 14 16 23 29
Waluta USD USD USD USD USD USD USD USD